Abstract:Importance: Incidence rates for lower extremity deep vein thrombosis (DVT) range from 88 to 112 per 100 000 person-years and increase with age. Rates of recurrent VTE range from 20% to 36% during the 10 years after an initial event. Observations: PubMed and Cochrane databases were searched for English-language studies published from January 2015 through June 2020 for randomized clinical trials, meta-analyses, systematic reviews, and observational studies. Risk factors for venous thromboembolism (VTE), such as older age, malignancy (cumulative incidence of 7.4% after a median of 19 months), inflammatory disorders (VTE risk is 4.7% in patients with rheumatoid arthritis and 2.5% in those without), and inherited thrombophilia (factor V Leiden carriers with a 10-year cumulative incidence of 10.9%), are associated with higher risk of VTE. Patients with signs or symptoms of lower extremity DVT, such as swelling (71%) or a cramping or pulling discomfort in the thigh or calf (53%), should undergo assessment of pretest probability followed by D-dimer testing and imaging with venous ultrasonography. A normal D-dimer level (ie, D-dimer <500 ng/mL) excludes acute VTE when combined with a low pretest probability (ie, Wells DVT score ≤1). In patients with a high pretest probability, the negative predictive value of a D-dimer less than 500 ng/mL is 92%. Consequently, D-dimer cannot be used to exclude DVT without an assessment of pretest probability. Postthrombotic syndrome, defined as persistent symptoms, signs of chronic venous insufficiency, or both, occurs in 25% to 50% of patients 3 to 6 months after DVT diagnosis. Catheter-directed fibrinolysis with or without mechanical thrombectomy is appropriate in those with iliofemoral obstruction, severe symptoms, and a low risk of bleeding. The efficacy of direct oral anticoagulants-rivaroxaban, apixaban, dabigatran, and edoxaban-is noninferior to warfarin (absolute rate of recurrent VTE or VTE-related death, 2.0% vs 2.2%). Major bleeding occurs in 1.1% of patients treated with direct oral anticoagulants vs 1.8% treated with warfarin. Conclusions and relevance: Greater recognition of VTE risk factors and advances in anticoagulation have facilitated the clinical evaluation and treatment of patients with DVT. Direct oral anticoagulants are noninferior to warfarin with regard to efficacy and are associated with lower rates of bleeding, but costs limit use for some patients.

Thrombectomy with arteriovenous fistula for embolizing deep venous thrombosis: an alternative therapy for prevention of recurrent pulmonary embolism

Preventive and therapeutic approach to venous thromboembolic disease and pulmonary embolism—can death from pulmonary embolism be prevented?

Management of Deep Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline

Acute Venous Iliofemoral Thrombosis: Early Surgical Thrombectomy Is Effective and Durable

Long-term results after transfemoral venous thrombectomy for iliofemoral deep venous thrombosis

Longterm results after surgical thrombectomy and simultaneous stenting for symptomatic iliofemoral venous thrombosis

Thrombectomy Combined with Endovascular Therapy in Treatment of Deep Venous Thrombosis of Lower Extremities

Manual aspiration thrombectomy for acute and subacute inferior vena cava thrombosis and lower extremity deep venous thrombosis

Removal of Wall-Adherent Inferior Vena Cava Thrombus with a Combined Approach Using Vacuum-Assisted Thrombectomy and a Rotational Thrombectomy Device

Use of Percutaneous Aspiration Thrombectomy vs. Anticoagulation Therapy to Treat Acute Iliofemoral Venous Thrombosis: 1-year Follow-up Results of a Randomised, Clinical Trial

Syringe-assisted test-aspiration with mechanical aspiration thrombectomy results in good safety and short-term outcomes in the treatment of patients with deep venous thrombosis

NONANTICOAGULANT INTERVENTIONS IN VENOUS THROMBOEMBOLISM Thrombolytic therapy in acute venous thromboembolism

Vascular Intervention Plus Arteriovenous Fistula for the Treatment of Acute Deep Vein Thrombosis of the Lower Extremities

Efficacy of Mechanical Thrombectomy in Preventing Post-Thrombotic Syndrome in Acute DVT: A Retrospective Study

Thrombectomy monitoring by DSA combined with thrombolytic therapy for deep venous thrombosis of lower extremities

Interventional therapy for venous thromboembolism

Endovascular management of proximal lower limb deep venous thrombosis – A prospective study with six-month follow-up

Novel Challenges and Therapeutic Options for Pulmonary Embolism and Deep Vein Thrombosis

Diagnosis, Surgical Treatment, and Postoperative Care of Patients with Acute Thrombosis of the Femoral and Iliac Veins

A Review of the Effectiveness and Safety of Catheter-Directed Thrombolysis for Venous Thromboembolism

Diagnosis and Treatment of Lower Extremity Venous Thromboembolism: A Review